Arthritis Drug for Hair Loss?

Promising but not for everyone… Recently researchers at Yale published a case report in which a young man with alopecia areata regrew nearly all of his hair using a new medication called tofacitib (Xeljanz). We have received a lot of inquiries about this medication for other forms of hair loss such as male and female pattern hair loss, or cicatricial alopecia. What consumers need to know is that this medication is currently only FDA approved for rheumatoid arthritis, and will require further study before insurance carriers are willing to cover it for off-label indications. The cash price is currently around $2000/month. We are considering trial prescriptions on a case by case basis but only for patients who have advanced alopecia areata specifically. Even so many side effects have been reported so you will need to confer with Dr. Rogers extensively before moving forward.